An Open-Label, Dose-Escalating Study of the Pharmacokine

  • SHUKLA, ASEEM (PI)

Project: Research project

Description

An open-label, dose-escalating study of the pharmacokinetics, safety and tolerability of fesoterodine in pediatric overactive bladder patients aged 11-17 years
StatusFinished
Effective start/end date2/18/0912/31/10

Funding

  • PFIZER, INC.

Fingerprint

Overactive Urinary Bladder
Pharmacokinetics
Pediatrics
Safety
fesoterodine